Who
Michel Revel
CSO and Director
Company insider
Files Form 4 as: CSO and Director, NewcelX.
In numbers
- Trades disclosed
- 4
- Buys
- 1
- Sells
- 0
- Bought
- $300K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 27 Apr 2026
- Last trade
- 27 Apr 2026
- Last filed
- 29 Apr 2026
Companies traded
Activity over time
1 Apr – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 27 Apr 2026filed 29 Apr 2026 | NCEL NewcelXBiotechnology | SEC FORM 4 Bought | $150K54,545 at $2.75 | filing |
| 27 Apr 2026filed 29 Apr 2026 | NCEL NewcelXoption or derivative · Biotechnology | SEC FORM 4 Code P | —76,363 | filing |
| 27 Apr 2026filed 29 Apr 2026 | NCEL NewcelXoption or derivative · Biotechnology | SEC FORM 4 Code P | —76,363 | filing |
| 27 Apr 2026filed 29 Apr 2026 | NCEL NewcelXBiotechnology | SEC FORM 4 Bought | $150K54,545 at $2.75 | filing |
News
No headline names them, or the companies they trade most, lately.